Device Found, but Not a Case of Patent Infringement: Examining the Order in Conqueror Innovations v Xiaomi

/ By / Patent

Many of the readers who own a Xiaomi device would be familiar with the company’s ‘Find Device’ feature that allows users to perform features on their phone remotely, including the ability to track, lock or even erase data from it. This functionality was at the centre of an important order recently where the Delhi HC refused to issue an interim injunction against Xiaomi from using its ‘Find Device’ feature on the allegations of patent infringement raised by the plaintiff, a […]

Device Found, but Not a Case of Patent Infringement: Examining the Order in Conqueror Innovations v Xiaomi Read More »

A Quick Look at the Draft Patent Rules 2025: What’s New(and Old)?

/ By / Patent

It’s 2025, and the Ministry of Commerce and Industry released another set of draft rules in order to amend the Patent Rules 2003. The notification mentions that the draft rules will be taken into consideration after the expiry of a period of thirty days from the date of their public availability through the gazette (the e-gazette website shows the issue date as 17 July 2025 and the publish date as 18 July 2025, while the notification itself is headlined with

A Quick Look at the Draft Patent Rules 2025: What’s New(and Old)? Read More »

https://upload.wikimedia.org/wikipedia/en/a/ae/Raanjhanaafilmposter.jpg

Raanjhanaa on the Big Screen (Again): Analysing the IPR Issues Triggered by An AI-Generated Ending

/ By / Copyright, Innovation

[A big thanks to Lokesh for his inputs in the post] The impending re-release of Raanjhanaa on August 1, 2025, with an AI-generated alternate ending, has reignited the long-standing tension between ownership and authorship. At a time when AI continues to be viewed with scepticism, especially within creative industries, this development adds another layer to the growing unease around artistic integrity. This isn’t the first time AI has stirred controversy in entertainment. I recall covering a similar flashpoint last year,

Raanjhanaa on the Big Screen (Again): Analysing the IPR Issues Triggered by An AI-Generated Ending Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (July 21 – July 27)

/ By / Copyright, Others, Patent, Trademark

Would the Delhi HC’s injunction order against Zydus set a dangerous precedent on stockpiling? A post touching upon this issue. The India-UK CETA carries forward some problematic elements from the 2022 leaked draft version – a post exploring the agreement on key IP sections. Where exactly are we headed in the GM Crops regime? A post holistically analysing the GM regime in India and the impact it may have. This and much more in our weekly roundup of our blog

SpicyIP Weekly Review (July 21 – July 27) Read More »

Taking a Look at the Patent Provisions from the India-UK CETA: Does it Set a Course for Future Trade Negotiations for India?

/ By / Patent

Two months after showing up in the news, the text of the India-UK Comprehensive Economic and Trade Agreement (CETA) was signed and published on July 24. The Agreement is being touted as a “Historic” and “Landmark” trade deal, which is supposed to give unprecedented market access to Indian goods in the UK. This comes at an interesting time, in the midst of ongoing India-US trade agreement talks, which are being conducted under the looming threat of August 1 reciprocal tariff

Taking a Look at the Patent Provisions from the India-UK CETA: Does it Set a Course for Future Trade Negotiations for India? Read More »

E.R. Squibb v. Zydus: Why the Delhi HC’s Take on Biosimilars May Set a Dangerous Precedent

/ By / Drug Regulation, Patent

In the past two months, Zydus Lifesciences has faced two legal setbacks in litigations for its biosimilar medicines. In April, the U.S. District Court of Delaware rejected Zydus’s challenge against the validity of Astellas’s patent on Myrbetriq, dealing a blow to Zydus’s plan to launch a generic version of the drug in U.S. On 18th July, the Delhi HC dealt another blow– it restrained Zydus from manufacturing, selling, offering for sale, importing, exporting, advertising or dealing in any bio-similar of Nivolumab.  The

E.R. Squibb v. Zydus: Why the Delhi HC’s Take on Biosimilars May Set a Dangerous Precedent Read More »

Reframing Procedural Fairness in Patent Amendments: A Comparative Look at Dong Yang and Srinivas Jegannathan’s Reversals

/ By / Patent

Explaining two recent judgements on amendments- Dong Yang PC Inc. v Controller of Patents and Designs (Delhi HC) and Srinivas Jegannathan v Controller of Patents (Madras HC), S. Sri Ganesh Prasad, argues how they point towards the need for the patent office to fulfil its quasi-judicial role in patent prosecution with clarity and evidence. Ganesh is a third-year B.A. LL.B. (Hons.) student at the West Bengal National University of Juridical Sciences (WBNUJS), Kolkata. He is interested in a wide range

Reframing Procedural Fairness in Patent Amendments: A Comparative Look at Dong Yang and Srinivas Jegannathan’s Reversals Read More »

Prima Facie, Not Per Se: Rebuilding SEP Interim Jurisprudence after Nokia v Oppo

/ By / Patent

On the recent Delhi High Court decision in Dolby v. Lava, directing the India-based implementer to pay INR 20.81 Crores as pro-tem security, Shailraj Jhalnia argues for a more balanced approach on how the Courts should calculate such deposits, keeping in mind the interests of both the SEP holders and implementers. Shailraj is a third year law student pursuing B.A. LL.B. from National Law School of India University, Bangalore, with a keen interest in IP Law, Arbitration and Criminal Law.

Prima Facie, Not Per Se: Rebuilding SEP Interim Jurisprudence after Nokia v Oppo Read More »

https://i.imgflip.com/a0vx9q.jpg

Keeping Up with The (GM) Crops: Comments and Caveats on the GEAC’s Punjab GM Crop Trials

/ By / Innovation

[A big thanks to Daanish Naithani for his inputs in the post.] If you were following the Genetically Modified (GM) crops dilemma last year but failed to keep up over the past year, don’t worry. Fortunately (and unfortunately, when seen in the broader scope), you haven’t really missed much. In July last year, as covered here on the blog, the Supreme Court (SC) delivered a split verdict on the commercial sale of Genetically Modified Mustard (GM Mustard) in India in

Keeping Up with The (GM) Crops: Comments and Caveats on the GEAC’s Punjab GM Crop Trials Read More »

[Sponsored] Crack the Patent Agent Exam – Join India’s Most Trusted Training Program

/ By / Courses & Workshops, Patent, Sponsored

Edu Literati is now inviting applications for its Patent Agent Exam 2026 Training Programme. The programme fee is ₹25,000 and SpicyIP readers can avail a 20% discount by using the coupon code SPICYIP at checkout. This special offer is valid for a limited number of seats, so early registration is recommended. To learn more about the programme, check out the details below: [Sponsored] Crack the Patent Agent Exam – Join India’s Most Trusted Training Program The Indian Patent Office has

[Sponsored] Crack the Patent Agent Exam – Join India’s Most Trusted Training Program Read More »

Scroll to Top